Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Diabetes Technology & Therapeutics|February 1, 2022
Insulin Pump Infusion Set Failures Associated with Prolonged Hyperglycemia: Frequency and Relationship to Age and Type of Infusion Set During 22,741 Infusion Set WearsLauren G Kanapka, John W Lum, Roy W BeckDiabetes Technology & Therapeutics|January 23, 2026
Consistent Benefit of Control-IQ+ Automated Insulin Delivery Across a Range of Characteristics of Adults with Type 2 DiabetesLakshmi G Singh, John W Lum, Lauren Kanapka, et al.Diabetes Technology & Therapeutics|January 12, 2022
Glycemic Outcomes in Baseline Hemoglobin A1C Subgroups in the International Diabetes Closed-Loop TrialLaya Ekhlaspour, Marissa Town, Dan Raghinaru, et al.Diabetes Technology & Therapeutics|April 2, 2025
Reduction of Postprandial Glucose Excursions in Adults, Adolescents, and Children with Type 1 Diabetes Using Ultra-Rapid Lispro Insulin and Control-IQ+ TechnologyGrazia Aleppo, Peter Calhoun, Ryan Bailey, et al.Diabetes Technology & Therapeutics|January 31, 2022
Insulin Delivery and Glucose Variability Throughout the Menstrual Cycle on Closed Loop Control for Women with Type 1 DiabetesCarol J Levy, Grenye O'Malley, Dan Raghinaru, et al.Diabetes Care|September 15, 2025
Adults With Type 2 Diabetes Benefit From Automated Insulin Delivery Irrespective of C-Peptide LevelIrl B Hirsch, Yogish C Kudva, David T Ahn, et al.Diabetes Care|November 20, 2025
Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 DiabetesTimothy E Graham, Dan Raghinaru, Samina Afreen, et al.Diabetes Technology & Therapeutics|November 20, 2025
Simplified Meal Bolus Strategies with Control-IQ+ Automated Insulin Delivery Are Safe and Effective in Adults with Type 2 DiabetesCarol J Levy, Lauren Kanapka, Sue A Brown, et al.Journal of Diabetes Science and Technology|April 27, 2022
Outcomes in Pump- and CGM-Baseline Use Subgroups in the International Diabetes Closed-Loop TrialLaya Ekhlaspour, Dan Raghinaru, Gregory P Forlenza, et al.Diabetes Technology & Therapeutics|November 15, 2021
Discontinued Use of the Loop Insulin Dosing System: A Mixed-Methods InvestigationJessie J Wong, Sakinah C Suttiratana, Rayhan A Lal, et al.Pageof 3